Evidence map›Paper›PMID 40880004›Full record

ArticleAIDS and behavior2026

Empowering Women's PrEP Choices: Qualitative Insights into Long-Acting PrEP Preferences and Decision-Making during Pregnancy and Breastfeeding in South Africa and Botswana.

Jenny Chen-Charles, Lindsey De Vos, Prisca Vundhla, Avuyonke Gebengu, Elzette Rousseau, Linda-Gail Bekker, Remco Peters, Aamirah Mussa, Chelsea Morroni, Elona Toska and 3 more

Erratum issuedAbstract read
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Jenny Chen-CharlesDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa. jenny.chen1@alumni.lshtm.ac.uk.ORCID http://orcid.org/0000-0002-5040-0905
Lindsey De VosDesmond Tutu Health Foundation, Cape Town, South Africa.
Prisca VundhlaDesmond Tutu Health Foundation, Cape Town, South Africa.
Avuyonke GebenguFoundation for Professional Development, East London, South Africa.
Elzette RousseauDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Linda-Gail BekkerDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Remco PetersDepartment of Medical Microbiology, University of Pretoria, Pretoria, South Africa.
Aamirah MussaBotswana Harvard Health Partnership, Gaborone, Botswana.
Chelsea MorroniBotswana Harvard Health Partnership, Gaborone, Botswana.
Elona ToskaDepartment of Social Policy and Intervention, University of Oxford, Oxford, UK.
Chibuzor M BabalolaDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, USA.
Jeffrey D KlausnerDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, USA.
Dvora Joseph DaveyDepartment of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.

Funding

Merck Merck Investigator Initiated Studies Program
6 · The paper itself

Abstract

Pregnant and breastfeeding women (PBW) are at heightened risk of HIV acquisition. We aimed to explore PBW's preferences of various long-acting PrEP modalities. In-depth interviews were conducted with PBW at three sites: Cape Town, East London (South Africa), and Gaborone (Botswana). We conducted thematic analysis, guided by the Health Belief Model, to examine participants' HIV risk perception during pregnancy and breastfeeding, their perceived individual-level facilitators and barriers of each PrEP modality, and the support needed by participants for PrEP uptake and continuation. 40 participants were interviewed, aged 18-39 years (mean 27 years), including 13 adolescent girls and young women (AGYW; 18-24 years). Participants were either pregnant (n = 20) or breastfeeding (n = 20). Perceived HIV risk during pregnancy motivated PrEP use. Long-acting methods were preferred over daily pills for convenience and perceived reliability, with injectables most favoured due to familiarity with contraceptive injections. However, concerns about pain and side effects persisted. Monthly oral PrEP was seen as easier than daily pills but raised similar concerns about adherence. Implants were met with fear and mistrust, often rooted in negative contraceptive experiences, though some valued their long-term protection. The vaginal ring was least acceptable due to unfamiliarity and discomfort with insertion. Participants emphasised the importance of external support (e.g. reminders), privacy and discretion, and community transparency to support PrEP adherence and reduce stigma. Addressing barriers - especially concerns about the safety and effectiveness of new modalities and challenges around adherence - could help improve strategies to better assist PBW in utilising long-acting PrEP modalities.

Indexed as

Anti-HIV AgentsBreast FeedingDecision MakingHIV InfectionsInfectious Disease Transmission, VerticalPatient PreferencePre-Exposure ProphylaxisPregnancy Complications, InfectiousPregnant PeopleAdolescentAdultBotswanaFemaleHealth Knowledge, Attitudes, PracticeHumansInterviews as TopicAnti-HIV AgentsAdolescent girls and young womenHIV preventionLong-acting PrEPPre-exposure prophylaxisPregnant and breastfeeding womenPrEPSub-Saharan africa

Identifiers

PMID40880004
PMCPMC12816032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.